【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. High Investment For R&D Activities Pertaining To Gene Therapy
3.5.1.2. Increase In Prevalence of Cancer
3.5.1.3. Growth In Awareness Regarding Gene Therapy
3.5.2. Restraints
3.5.2.1. High Cost Associated With Gene Therapies
3.5.2.2. Unwanted Immune Responses
3.5.3. Opportunities
3.5.3.1. Untapped Potential For Emerging Markets
Chapter 4: Gene Therapy Market, By Vector Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Viral Vectors
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Size And Forecast, By Type
4.2.4. Market Size And Forecast, By Country
4.2.5. Adenovirus
4.2.6. Lentivirus
4.2.7. Retrovirus
4.2.8. Adeno-Associated Virus
4.2.9. Herpes Simplex Virus
4.2.10. Poxvirus
4.2.11. Vaccinia Virus
4.2.12. Others
4.3. Non-Viral Techniques
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Size And Forecast, By Type
4.3.4. Market Size And Forecast, By Country
4.3.5. Naked Plasmid Vector
4.3.6. Gene Gun
4.3.7. Electroporation
4.3.8. Lipofection
4.3.9. Others
Chapter 5: Gene Therapy Market, By Gene Type
5.1. Overview
5.1.1. Market Size And Forecast, Type
5.2. Antigen
5.2.1. Market Size And Forecast
5.2.2. Market Size And Forecast, By Country
5.3. Cytokine
5.3.1. Market Size And Forecast
5.3.2. Market Size And Forecast, By Country
5.4. Tumor Suppressor
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Size And Forecast, By Country
5.5. Suicide Gene
5.5.1. Market Size And Forecast
5.5.2. Market Size And Forecast, By Country
5.6. Deficiency
5.6.1. Market Size And Forecast, By Region
5.6.2. Market Size And Forecast, By Country
5.7. Growth Factors
5.7.1. Market Size And Forecast, By Region
5.7.2. Market Size And Forecast, By Country
5.8. Receptors
5.8.1. Market Size And Forecast, By Region
5.8.2. Market Size And Forecast, By Country
5.9. Others
5.9.1. Market Size And Forecast, By Region
5.9.2. Market Size And Forecast, By Country
Chapter 6: Gene Therapy Market, By Application
6.1. Overview
6.1.1. Market Size And Forecast, By Application
6.2. Oncological Disorders
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Size And Forecast, By Country
6.3. Rare Diseases
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Size And Forecast, By Country
6.4. Cardiovascular Diseases
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Size And Forecast, By Country
6.5. Neurological Disorders
6.5.1. Market Size And Forecast
6.5.2. Market Size And Forecast, By Country
6.6. Infectious Diseases
6.6.1. Market Size And Forecast, By Region
6.6.2. Market Size And Forecast, By Country
6.7. Other Diseases
6.7.1. Market Size And Forecast
6.7.2. Market Size And Forecast, By Country
Chapter 7: Gene Therapy Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.3. Market Size And Forecast, By Vector Type
7.2.4. Market Size And Forecast, By Gene Type
7.2.5. Market Size And Forecast, By Application
7.2.5.1. U.S. Market Size And Forecast, By Vector Type
7.2.5.2. U.S. Market Size And Forecast, By Gene Type
7.2.5.3. U.S. Market Size And Forecast, By Application
7.2.5.4. Canada Market Size And Forecast, By Vector Type
7.2.5.5. Canada Market Size And Forecast, By Gene Type
7.2.5.6. Canada Market Size And Forecast, By Application
7.2.5.7. Mexico Market Size And Forecast, By Vector Type
7.2.5.8. Mexico Market Size And Forecast, By Gene Type
7.2.5.9. Mexico Market Size And Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.3. Market Size And Forecast, By Vector Type
7.3.4. Market Size And Forecast, By Gene Type
7.3.5. Market Size And Forecast, By Application
7.3.5.1. Germany Market Size And Forecast, By Vector Type
7.3.5.2. Germany Market Size And Forecast, By Gene Type
7.3.5.3. Germany Market Size And Forecast, By Application
7.3.5.4. France Market Size And Forecast, By Vector Type
7.3.5.5. France Market Size And Forecast, By Gene Type
7.3.5.6. France Market Size And Forecast, By Application
7.3.5.7. Uk Market Size And Forecast, By Vector Type
7.3.5.8. Uk Market Size And Forecast, By Gene Type
7.3.5.9. Uk Market Size And Forecast, By Application
7.3.5.10. Italy Market Size And Forecast, By Vector Type
7.3.5.11. Italy Market Size And Forecast, By Gene Type
7.3.5.12. Italy Market Size And Forecast, By Application
7.3.5.13. Spain Market Size And Forecast, By Vector Type
7.3.5.14. Spain Market Size And Forecast, By Gene Type
7.3.5.15. Spain Market Size And Forecast, By Application
7.3.5.16. Rest of Europe Market Size And Forecast, By Vector Type
7.3.5.17. Rest of Europe Market Size And Forecast, By Gene Type
7.3.5.18. Rest of Europe Market Size And Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.3. Market Size And Forecast, By Vector Type
7.4.4. Market Size And Forecast, By Gene Type
7.4.5. Market Size And Forecast, By Application
7.4.5.1. Japan Market Size And Forecast, By Vector Type
7.4.5.2. Japan Market Size And Forecast, By Gene Type
7.4.5.3. Japan Market Size And Forecast, By Application
7.4.5.4. China Market Size And Forecast, By Vector Type
7.4.5.5. China Market Size And Forecast, By Gene Type
7.4.5.6. China Market Size And Forecast, By Application
7.4.5.7. India Market Size And Forecast, By Vector Type
7.4.5.8. India Market Size And Forecast, By Gene Type
7.4.5.9. India Market Size And Forecast, By Application
7.4.5.10. South Korea Market Size And Forecast, By Vector Type
7.4.5.11. South Korea Market Size And Forecast, By Gene Type
7.4.5.12. South Korea Market Size And Forecast, By Application
7.4.5.13. Rest of Asia-Pacific Market Size And Forecast, By Vector Type
7.4.5.14. Rest of Asia-Pacific Market Size And Forecast, By Gene Type
7.4.5.15. Rest of Asia-Pacific Market Size And Forecast, By Application
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.3. Market Size And Forecast, By Vector Type
7.5.4. Market Size And Forecast, By Gene Type
7.5.5. Market Size And Forecast, By Application
7.5.5.1. Brazil Market Size And Forecast, By Vector Type
7.5.5.2. Brazil Market Size And Forecast, By Gene Type
7.5.5.3. Brazil Market Size And Forecast, By Application
7.5.5.4. South Africa Market Size And Forecast, By Vector Type
7.5.5.5. South Africa Market Size And Forecast, By Gene Type
7.5.5.6. South Africa Market Size And Forecast, By Application
7.5.5.7. Rest of Lamea Market Size And Forecast, By Vector Type
7.5.5.8. Rest of Lamea Market Size And Forecast, By Gene Type
7.5.5.9. Rest of Lamea Market Size And Forecast, By Application
Chapter 8: Company Profile
8.1. Adaptimmune Therapeutics Plc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments
8.2. Anchiano Therapeutics Ltd.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.3. Achieve Life Sciences, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves And Developments
8.4. Adverum Biotechnologies, Inc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves And Developments
8.5. Abeona Therapeutics Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments
8.6. Applied Genetic Technologies Corporation
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves And Developments
8.7. Arbutus Biopharma Corporation
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Product Portfolio
8.7.4. Business Performance
8.7.5. Key Strategic Moves And Developments
8.8. Audentes Therapeutics Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Product Portfolio
8.8.4. Key Strategic Moves And Developments
8.9. Avexis Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Product Portfolio
8.9.4. Key Strategic Moves And Developments
8.10. Bluebird Bio, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves And Developments
8.11. Celgene Corporation
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.11.6. Key Strategic Moves And Developments
8.12. Crispr Therapeutics Ag
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Product Portfolio
8.12.4. Business Performance
8.12.5. Key Strategic Moves And Developments
8.13. Editas Medicine, Inc.
8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.13.4. Product Portfolio
8.13.5. Business Performance
8.13.6. Key Strategic Moves And Developments
8.14. Gilead Sciences, Inc.
8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Operating Business Segments
8.14.4. Product Portfolio
8.14.5. Business Performance
8.14.6. Key Strategic Moves And Developments
8.15. Glaxosmithkline Plc
8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Operating Business Segments
8.15.4. Product Portfolio
8.15.5. Business Performance
8.15.6. Key Strategic Moves And Developments
8.16. Intellia Therapeutics Inc.
8.16.1. Company Overview
8.16.2. Company Snapshot
8.16.3. Operating Business Segments
8.16.4. Product Portfolio
8.16.5. Business Performance
8.16.6. Key Strategic Moves And Developments
8.17. Merck & Co., Inc.
8.17.1. Company Overview
8.17.2. Company Snapshot
8.17.3. Operating Business Segments
8.17.4. Product Portfolio
8.17.5. Business Performance
8.17.6. Key Strategic Moves And Developments
8.18. Novartis Ag
8.18.1. Company Overview
8.18.2. Company Snapshot
8.18.3. Operating Business Segments
8.18.4. Product Portfolio
8.18.5. Business Performance
8.18.6. Key Strategic Moves And Developments
8.19. Regenxbio, Inc.
8.19.1. Company Overview
8.19.2. Company Snapshot
8.19.3. Product Portfolio
8.19.4. Business Performance
8.19.5. Key Strategic Moves And Developments
8.20. Spark Therapeutics, Inc.
8.20.1. Company Overview
8.20.2. Company Snapshot
8.20.3. Operating Business Segments
8.20.4. Product Portfolio
8.20.5. Business Performance
8.20.6. Key Strategic Moves And Developments
8.21. Sangamo Therapeutics, Inc.
8.21.1. Company Overview
8.21.2. Company Snapshot
8.21.3. Operating Business Segments
8.21.4. Product Portfolio
8.21.5. Business Performance
8.21.6. Key Strategic Moves And Developments
8.22. Uniqure N. V.
8.22.1. Company Overview
8.22.2. Company Snapshot
8.22.3. Operation Segments
8.22.4. Product Portfolio
8.22.5. Business Performance
8.22.6. Key Strategic Moves And Developments
8.23. Voyager Therapeutics, Inc.
8.23.1. Company Overview
8.23.2. Company Snapshot
8.23.3. Operating Business Segments
8.23.4. Product Portfolio
8.23.5. Business Performance
8.23.6. Key Strategic Moves And Developments
【レポート販売概要】
■ タイトル：遺伝子治療の世界市場：ベクター種類別（ウイルスベクター、非ウイルスベクター）、遺伝子種類別（抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他）、用途別（腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他）■ 英文：Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年12月31日
■ 調査会社：Allied Market Research
■ 商品コード：AMR20FE041
■ 調査対象地域：グローバル
- ダイボンダー装置の世界市場2017-2021ABSTRACTAbout Die Bonder Equipment Die bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are separated from the defective ones, which are already marked before this step. bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are s …
- 介入的脊椎装置の世界市場2017-2021：椎体形成術、椎骨形成術、ラジオ波焼灼術About Interventional Spine Devices Interventional spine procedures are used to treat painful spinal conditions. Interventional treatment options are often more efficient and effective than traditional therapy for spinal (back and neck) pain. The new techniques are excellent minimally invasive alternatives to conventional surgery. Lumbar disc disease, sacroiliac joint, and degenerative lumbar facet …
- SMAC（ソーシャルメディア/モバイル/アナリティクス/クラウド）市場：市場機会及び予測The convergence of social media, mobile, analytics, and cloud (SMAC) is one of the most impactful trends for both consumer and enterprise realization within digital media, communications, applications, content, and commerce. Instead of implementing solutions separately SMAC encourages an organization to build and deploy integrated solutions wherein social/mobile adds connectedness and cloud/analyt …
- バイオポリアミドの世界市場2015-2019About bio-polyamide Polyamides are polymers that can be used to structurally and characteristically replace metal, wood, glass, or ceramic in various applications. Polyamide has unique thermal, mechanical, electrical, and acoustic properties, which makes it a versatile product. It is a high-performance material that is available at a competitive price. Bio-based polyamide is in high demand as it i …
- グローバルにおける製油産業動向Global Refining Capital Expenditures Forecast at over $300billion for New Capacity on-line by 2020; Refining Margins to Remain Under Pressure as Annual Capacity Increases Forecast to Exceed Growth in Annual Oil Demand Summary Report provides an overview of the forecast increases, on an annual basis, of the global and refining crude distillation unit (CDU) expansions and associated capital expendit …
- 振動センサの世界市場2016-2020About Vibration Sensor Vibration monitoring is an important part of predictive machine maintenance, which is an intelligent way to monitor machine working and boost performance. It helps to reduce the maintenance cost of machines and enables personnel to identify problems in machine components such as electric motors and fans, and decide when they might need replacement. Apart from improving manuf …
- 防汚塗料の世界市場：船舶、リグ用途About Antifouling Coatings Antifouling coatings are paints or coatings applied to the hull of a boat, ship, or yacht to reduce the growth of organisms on the part of the ship that is under water and to prevent corrosion of metal hulls. The application of such coatings improves the durability and performance of the vessel. In addition, antifouling coatings are used in fixed and floating offshore oi …
- 生コンクリートの世界市場2017-2021ABSTRACTAbout Readymix Concrete Ready-mix concrete is manufactured in a factory or a plant, within certain specific guidelines, and then delivered to the construction site through a truck equipped with transit mixers. Ready-mix concrete is manufactured in a factory or a plant, within certain specific guidelines, such as in the ratio of 3:2:1, i.e., 3 parts aggregates, 2 parts water, and 1 part cem …
- プロバイオティクス化粧品の世界市場2019-2023About this market High demand for beauty products among men to drive market growth. Beauty products witness high demand from men and women equally. Therefore, vendors are emphasizing on developing beauty products for men. Hence, a wide variety of BPC products for men are available in the market across different categories such as skincare, hair care, and fragrances. Technavio’s analysts have predi …
- End-to-End M2M, Fifth EditionMachine-to-machine (M2M) communications is an emerging technology and industry sub-segment poised to change the way that business is conducted, impacting everything from traditional telephony and IT operations to ERP, SCM, public safety, homeland security, and more. Written by industry experts who have actually designed, implemented and operated M2M applications, End-to-End M2M Fifth Edition provi …
- ロシアの心臓血管外科用機器市場見通し（～2021）Russia Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "Russia Cardiovascular Surgery Outlook to 2021", provides key procedures data on the Russia Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast m …
- 世界のパワーアシスト車椅子市場（2014-2018）TechNavio's analysts forecast the Global Powered Wheelchairs market to grow at a CAGR of 21.5 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing elderly population. The Global Powered Wheelchairs market has also been witnessing the introduction of lightweight smart chairs. However, the presence of substitutes could pose a challenge to the …
- Leishmaniasis (Kala-Azar)：グローバル臨床試験レビューH1, 2013Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2013" provides data on the Leishmaniasis (Kala-Azar) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leishmaniasis (Kala-Azar). It includes an overview of the trial …
- 運動失調（Ataxia）：グローバル臨床試験レビュー（2014年上半期）Ataxia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- プログラマブルオートメーションコントローラーの世界市場展望2017-20276According to Stratistics MRC, the Global Programmable Automation Control Market expected to grow at a CAGR of 4.3% during the forecast period. Some of the key factors fueling the market are increasing demand for the high-performance and powerful functionality controller for satisfying the complex control requirements of the industries. However, demand for customization of products and gradual shif …
